Australia Patient Monitoring Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

Market Overview

The Australia patient monitoring market blends a hardware replacement cycle with fast-growing connected care. Public and private hospitals renew bedside monitors, central stations and sensors, while state health services add home kits, wearables and software that let clinicians watch patients outside the ward. Recurring sensors, licences and service contracts add revenue after each installation.

Three forces shape the outlook: virtual wards that treat patients at home, wireless wearables that replace cabled sensors, and hospital software that links monitors to patient flow and electronic records. Regulation of software and wearables, and tender-based public purchasing, influence which suppliers win.

In December 2025 Victoria began a Virtual Hospital pilot, and in March 2026 Alcidion signed a five-year remote monitoring contract with Gold Coast Health. In August 2026 Philips widened its open monitoring ecosystem with six wearable and home-care partners.

Key Market Trends and Insights

• Virtual hospital investment: The Victorian Government is investing $6.1 million in its Virtual Hospital Pilot, which runs to the end of June 2027 and had treated more than 600 Victorians by August 2026.
• Home kit scope: Metro North Health's virtual ward in Queensland supplies four free home devices, covering oxygen saturation, blood pressure, temperature and weight, and operates seven days a week.
• Digital reform funding: The Federal Budget in May 2026 allocated A$79.2 million over three years to help states and territories implement national digital health reforms in public hospitals.
• Recurring revenue: Alcidion reported new sales of A$11.7 million in the March 2026 quarter, about 90% recurring product revenue, including its five-year Gold Coast Health remote monitoring contract.

Australia Patient Monitoring Market Size and Forecast

The market is moving from stand-alone bedside monitors towards connected systems in which sensors, wearables and software feed one clinical record. Multi-Parameter Monitors remain the core installed base, while Remote and Wearable Monitoring Devices add the most momentum. Critical and Perioperative Care holds the largest application share, with Cardiology advancing fastest. Hospitals lead purchasing, and Home Care Settings gain share. New South Wales is the largest region and Queensland grows quickest. Service contracts, sensor consumables and clinical analytics software underpin a steady mid-to-high single-digit outlook. Australian health services also weigh clinician workload and cybersecurity when choosing platforms.

Key Takeaways: Australia Patient Monitoring Market

Connected Care Lifts Revenue

Revenue is on course to roughly double across the decade, from AUD 420.00 million in 2025 to AUD 833.96 million in 2035 at a 7.1% CAGR. Replacement cycles, virtual wards and recurring sensor and software spend make demand durable.

Wearables and Home Care Lead Growth

Remote and Wearable Monitoring Devices grow at an estimated 12.4% CAGR and Home Care Settings at an estimated 11.2% CAGR through 2035. Cardiology advances at 8.1% as heart failure and post-surgical patients move into virtual wards.

Public Programmes and Software Shape Purchasing

State virtual care pilots, federal digital health funding and Medicare telehealth support influence where monitoring budgets go. Suppliers that pair devices with integration software and service gain bargaining power. Cybersecurity, interoperability and clinician workload increasingly decide tender outcomes.

• Victoria began its Virtual Hospital in December 2025
• A$79.2 million for hospital digital reforms in May 2026
• Gold Coast Health signed a five-year remote monitoring contract

Australia Patient Monitoring Market Report Summary

Key Insight

An ageing population, chronic disease and hospital-at-home programmes sustain monitor renewal, while wireless sensors and software add value. Hospitals lead purchasing and the northern states grow fastest.

Key Trends in the Australia Patient Monitoring Market

The Australia patient monitoring market is being reshaped by virtual hospitals, home monitoring kits, federal digital health funding and expanded Medicare telehealth support.

August 2026 - Victoria's Virtual Hospital Pilot Passes 600 Patients

• The Victorian Department of Health page, updated on 25 August 2026, reported that more than 600 Victorians had received care since the pilot began.
• The Victorian Government is investing $6.1 million, and the pilot runs until the end of June 2027, led by the Royal Melbourne Hospital and Austin Health.
• Patients with heart failure or recovering from cardiac surgery receive remote monitoring and regular virtual check-ins.

June 2026 - Metro North Health Details Its Virtual Ward Home Kit

• A June 2026 update from Metro North Health describes a virtual ward based at the Royal Brisbane and Women's Hospital, open from 7:00 am to 7:30 pm seven days a week.
• Patients receive an oxygen saturation probe, blood pressure monitor, thermometer and scales delivered to the home where required.
• General practitioners can view daily progress through the Health Provider Portal, which links home readings with community care.

May 2026 - Federal Budget Funds Hospital Digital Reforms

• The Federal Budget in May 2026 provided A$79.2 million over three years for states and territories to implement national digital health reforms in public hospitals.
• The same budget funded My Health Record operations and enhancements to support the Modernising My Health Record (Sharing by Default) Act 2025.
• Better data sharing improves the case for monitoring systems that can export readings to shared records.

March 2026 - Medicare Adds Telehealth Patient-End Support Items

• From 1 March 2026 new Medicare Benefits Schedule telehealth patient-end support items for general practitioners and nurse practitioners took effect, according to Services Australia.
• The same date brought new or updated diagnostic items, and ended the 85% out-of-hospital benefit for more than 100 items.
• Funding for the patient end of a video consultation supports clinics that use connected devices to share readings during remote reviews.

Key Insight

Virtual wards, wireless sensors and shared digital records move monitoring from the bedside into the home. Public funding and telehealth support encourage health services to invest in connected platforms.

Recent Market Developments in the Australia Patient Monitoring Market

Recent developments, presented from the most recent, show the Australia patient monitoring market moving through local software contracts, global ecosystem partnerships, oximetry innovation and new vital signs monitors.

August 2026 - Alcidion Reports Remote Monitoring Contract Live in Queensland

• On 19 August 2026 Alcidion reported full-year results, noting its five-year Gold Coast Health remote monitoring contract had recently gone live.
• It was the first Miya Precision customer in Queensland, extending virtual care into patients' homes.
• Alcidion completed the Kyra flow acquisition on 29 June 2026, adding 31 customers in Australia and New Zealand.

August 2026 - Philips Expands Its Open Patient Monitoring Ecosystem

• On 6 August 2026 Royal Philips announced collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree and smartQare.
• The partners add wearable temperature, blood pressure, multiparameter and respiratory sensors to the Patient Information Center iX platform.
• Philips says monitoring now extends beyond the bedside, supporting hospital-at-home and transitional care.

June 2026 - Medtronic Wins Clearance for Nellcor with Nell-EQ

• On 8 June 2026 Medtronic announced United States clearance for a Nellcor pulse oximetry system using the Nell-EQ intelligent processor.
• The system aims to deliver steadier readings across skin tones and also supports Perfusion Index and Heart Rate Variability.
• Global sales were planned for the following months, and Australian availability is not yet confirmed.

September 2025 - Baxter Launches the Welch Allyn Connex 360 Monitor

• On 16 September 2025 Baxter launched the Welch Allyn Connex 360 Vital Signs Monitor with United States regulatory clearance.
• It measures blood pressure, temperature, pulse rate, respiration rate and oxygen saturation, and sends results to the electronic medical record.
• Baxter's release described availability in the United States only, so Australian supply is not yet confirmed.

Key Insight

Local software firms win home monitoring contracts while global suppliers add wearables, improved oximetry and connected vital signs devices. Open platforms increasingly decide which sensors reach Australian wards.

Australia Patient Monitoring Industry Segmentation

The Expert Market Research’s report on the Australia Patient Monitoring Market offers a detailed analysis of the market based on the following segments.

Market Breakup by Device Type

• Multi-Parameter Monitors
• Cardiac Monitoring Devices
• Respiratory Monitoring Devices
• Neuromonitoring Devices
• Remote and Wearable Monitoring Devices
• Others

Multi-Parameter Monitors lead revenue, as hospitals renew bedside units and Baxter launched the Welch Allyn Connex 360 in September 2025. Cardiac Monitoring Devices cover telemetry, Holter and implantable recorders. Respiratory Monitoring Devices include pulse oximetry and capnography, where Medtronic announced Nellcor with Nell-EQ in June 2026. Neuromonitoring Devices cover depth-of-anaesthesia and brain activity monitoring in theatres. Remote and Wearable Monitoring Devices grow fastest at an estimated 12.4% CAGR, after Philips added six wearable and home-care partners in August 2026.

Market Breakup by Application

• Critical and Perioperative Care
• Cardiology
• Respiratory Disorders
• Neurology
• Others

Critical and Perioperative Care leads revenue, covering intensive care, emergency and theatre monitoring across public and private hospitals. Cardiology grows fastest at an estimated 8.1% CAGR, as Victoria's Virtual Hospital Pilot began with heart failure and post-cardiac care in December 2025. Respiratory Disorders benefit from home oximetry, with Metro North Health supplying oxygen saturation probes in its virtual ward in June 2026. Neurology covers seizure, stroke and sedation monitoring. Others includes maternal, neonatal and general ward observation.

Market Breakup by End User

• Hospitals
• Ambulatory Surgical and Diagnostic Centres
• Home Care Settings
• Others

Hospitals lead purchasing, supported by A$79.2 million of federal funding for state digital health reforms announced in May 2026. Ambulatory Surgical and Diagnostic Centres buy compact monitors, oximetry and cardiac recorders for day procedures. Home Care Settings grow fastest at an estimated 11.2% CAGR, as Gold Coast Health signed a five-year remote monitoring contract with Alcidion in March 2026. Others covers aged care facilities, general practice clinics and research sites.

Market Breakup by Region

• New South Wales
• Victoria
• Queensland
• Western Australia
• South Australia
• Others

New South Wales dominates through the largest population and hospital network, growing at an estimated 6.8% CAGR through 2035. Victoria follows at 7.5%, with its Virtual Hospital Pilot passing 600 patients by August 2026. Queensland is the fastest-growing region at an estimated 7.9%, helped by the Gold Coast Health contract and the Metro North virtual ward. Western Australia grows at 7.0% on distance-driven remote care needs. South Australia grows at 6.6%. Others covers Tasmania, the ACT and the Northern Territory at 6.9%.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Competitive Landscape in the Australia Patient Monitoring Market

Competition combines global monitor manufacturers with local software developers and distributors. Barriers include registration with the Therapeutic Goods Administration, clinical evidence, integration with hospital records, service coverage and cybersecurity assurance.

Philips

Philips, headquartered in Amsterdam, the Netherlands, supplies IntelliVue patient monitors, the Patient Information Center iX central station and cardiac monitoring through Philips Australia in Sydney. On 6 August 2026 it announced collaborations with six wearable and hospital-at-home partners to extend monitoring beyond the bedside. Its Mobile Cardiac Telemetry offer supports remote cardiac monitoring but is not available in all markets, so Australian availability should be checked.

GE HealthCare

GE HealthCare, headquartered in Chicago, Illinois, offers CARESCAPE and Portrait Mobile monitoring to Australian hospitals through its local subsidiary. On 3 March 2026 Medtronic announced a multi-year expansion of its alliance with GE HealthCare's Patient Care Solutions business. The scope covers bedside, telemetry, ambulatory and perioperative monitoring, integrating Nellcor, Microstream, INVOS and BIS parameters across its platforms.

Medtronic

Medtronic, headquartered in Galway, Ireland, supplies Nellcor pulse oximetry, Microstream capnography, INVOS oximetry and BIS brain monitoring in Australia through its regional subsidiary. On 8 June 2026 it announced United States clearance for Nellcor with the Nell-EQ intelligent processor, designed for reliability across skin tones. Its March 2026 alliance renewal with GE HealthCare broadens how these sensors reach hospital monitors.

Mindray

Mindray, headquartered in Shenzhen, China, supplies BeneVision patient monitors and transport monitors to Australian hospitals through a local subsidiary and distributors. In May 2025 it launched the BeneVision V Series at Euroanaesthesia in Lisbon, featuring a 4K top-end VMAX model and a cable-lite pod that sends vital signs wirelessly. The series also links with handheld ultrasound for a combined haemodynamic view.

Other players operating in the Australia patient monitoring market include Masimo, Baxter, Nihon Kohden, Dräger, and Alcidion, alongside regional distributors, cardiac monitoring service providers, wearable developers and clinical software vendors supplying monitoring equipment and support across Australia.

Key Insight

Competition rests on clinical accuracy, interoperability, service coverage and software ecosystems rather than price alone. Global manufacturers hold scale, while local software firms win connected care contracts.